ETAO International Co., Ltd. is a digital healthcare company, which engages in the provision of telemedicine, hospital care, primary care, pharmacy, and health insurance covering life stages of patients. The company is headquartered in New York City, New York and currently employs 3,600 full-time employees. The company went IPO on 2022-06-17. The firm provides a comprehensive healthcare service via the VIEs which will consist of both online and offline capabilities. Its services include online health insurance and pharmacy, digital diabetes management and biotech. Offline healthcare services consist of hospital and specialty clinics, such as infertility, orthopedic surgery, plastic surgery and primary care. The firm has developed an application for medical consultations delivered online. The company provides value added services via its end-to-end application solution, to patients by providing access to a network of contracted physicians, pharmacies, and medical supply vendors across many geographical regions to deliver medical consultations, medication, and supplies without patients having to leave their homes. The firm delivers medical services and quality care for Chinese patients via telemedicine and other services powered by technology.
Follow-Up Questions
ETAO International Co Ltd (ETAOF) 的本益比是多少?
ETAO International Co Ltd 的本益比是 0
ETAO International Co Ltd 的 CEO 是誰?
Mr. Wensheng Liu 是 ETAO International Co Ltd 的 Chairman of the Board,自 2018 加入公司。
ETAOF 股票的價格表現如何?
ETAOF 的當前價格為 0,在上個交易日 decreased 了 0%。
ETAO International Co Ltd 的主要業務主題或行業是什麼?
ETAO International Co Ltd 屬於 Health Care 行業,該板塊是 Health Care
ETAO International Co Ltd 的市值是多少?
ETAO International Co Ltd 的當前市值是 $0
ETAO International Co Ltd 是買入、賣出還是持有?
據華爾街分析師稱,共有 0 位分析師對 ETAO International Co Ltd 進行了分析師評級,包括 0 位強烈買入,0 位買入,0 位持有,0 位賣出,以及 0 位強烈賣出